Stifel Nicolaus analyst W. Andrew Carter maintained a Buy rating on Latham Group (SWIM – Research Report) today and set a price target of ...

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Masimo (MASI – Research Report), with a price ...

KILLINGTON — Killington Resort announced that tickets for the 2024 Stifel Killington Cup will be available for purchase beginning Sept. 17 at 10 a.m. The event will take place from Nov. 29 through Dec ...

Toronto-based Stifel Nicolaus Canada Inc. has agreed to pay the Canadian Investment Regulatory Organization (CIRO) a $475,000 fine for sharing potentially confidential information with clients.

At-the-Market Offering: On August 17, 2023, the Company entered into an equity distribution agreement (“August 2023 Equity ...

Stifel Financial Corp. is forming a new direct-lending joint venture with partners including a credit manager owned by Franklin Resources Inc. amid a growing wave of such partnerships. Stifel has ...

Fintel reports that on September 17, 2024, Stifel upgraded their outlook for Lattice Semiconductor (NasdaqGS:LSCC) from Hold to Buy. As of August 26, 2024, the average one-year price target for ...

The Osel Devices IPO GMP, or grey market premium, is +110 as per Investorgain.com. This indicates that Osel Devices shares were being sold on the Grey market for ₹110 more than their market value.

As of August 26, 2024, the average one-year price target for ORIC Pharmaceuticals is $19.09/share. The forecasts range from a low of $14.14 to a high of $26.25. The average price target represents ...